GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » Beneish M-Score

Nanjing Vishee Medical Technology Co (SHSE:688580) Beneish M-Score : -1.92 (As of May. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.92 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Nanjing Vishee Medical Technology Co's Beneish M-Score or its related term are showing as below:

SHSE:688580' s Beneish M-Score Range Over the Past 10 Years
Min: -2.5   Med: -1.83   Max: 5.18
Current: -1.92

During the past 10 years, the highest Beneish M-Score of Nanjing Vishee Medical Technology Co was 5.18. The lowest was -2.50. And the median was -1.83.


Nanjing Vishee Medical Technology Co Beneish M-Score Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co Beneish M-Score Chart

Nanjing Vishee Medical Technology Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5.18 0.24 -2.39 -2.06

Nanjing Vishee Medical Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.50 -2.29 -2.25 -2.06 -1.92

Competitive Comparison of Nanjing Vishee Medical Technology Co's Beneish M-Score

For the Medical Devices subindustry, Nanjing Vishee Medical Technology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing Vishee Medical Technology Co's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Vishee Medical Technology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Nanjing Vishee Medical Technology Co's Beneish M-Score falls into.



Nanjing Vishee Medical Technology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Nanjing Vishee Medical Technology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2185+0.528 * 1.0048+0.404 * 1.1869+0.892 * 1.2515+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0048+4.679 * -0.002505-0.327 * 0.7911
=-1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ¥42.8 Mil.
Revenue was 87.67 + 130.449 + 111.976 + 124.258 = ¥454.4 Mil.
Gross Profit was 61.53 + 94.738 + 80.079 + 88.683 = ¥325.0 Mil.
Total Current Assets was ¥1,222.2 Mil.
Total Assets was ¥1,796.5 Mil.
Property, Plant and Equipment(Net PPE) was ¥336.4 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥140.5 Mil.
Total Current Liabilities was ¥116.0 Mil.
Long-Term Debt & Capital Lease Obligation was ¥0.0 Mil.
Net Income was 21.753 + 34.578 + 31.124 + 40.476 = ¥127.9 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was 9.386 + 62.657 + 30.535 + 29.853 = ¥132.4 Mil.
Total Receivables was ¥28.1 Mil.
Revenue was 95.539 + 105.042 + 82.454 + 80.018 = ¥363.1 Mil.
Gross Profit was 68.21 + 74.172 + 59.994 + 58.596 = ¥261.0 Mil.
Total Current Assets was ¥1,318.8 Mil.
Total Assets was ¥1,721.1 Mil.
Property, Plant and Equipment(Net PPE) was ¥210.3 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥111.7 Mil.
Total Current Liabilities was ¥140.5 Mil.
Long-Term Debt & Capital Lease Obligation was ¥0.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(42.836 / 454.353) / (28.091 / 363.053)
=0.094279 / 0.077374
=1.2185

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(260.972 / 363.053) / (325.03 / 454.353)
=0.718826 / 0.715369
=1.0048

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1222.232 + 336.433) / 1796.524) / (1 - (1318.835 + 210.266) / 1721.089)
=0.1324 / 0.11155
=1.1869

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=454.353 / 363.053
=1.2515

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 210.266)) / (0 / (0 + 336.433))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(140.461 / 454.353) / (111.696 / 363.053)
=0.309145 / 0.307658
=1.0048

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 116.028) / 1796.524) / ((0 + 140.513) / 1721.089)
=0.064585 / 0.081642
=0.7911

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(127.931 - 0 - 132.431) / 1796.524
=-0.002505

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Nanjing Vishee Medical Technology Co has a M-score of -1.92 suggests that the company is unlikely to be a manipulator.


Nanjing Vishee Medical Technology Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
Executives
Huang He Senior management, core technical personnel
Chou Kai Senior management, core technical personnel
Zhong Yi Qun senior management
Chen Li Li Directors, senior managers
Zhang Hui senior management
Gao Fei Core technical personnel
Lian Qing Ming Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines